Clover Biopharmaceuticals Announces Publication of Phase 1 Clinical Trial Data for its Adjuvanted COVID-19 Vaccine Candidates in The Lancet
The Pharma Data
JANUARY 31, 2021
The S-Trimer vaccine candidates and adjuvants are expected to be stable long term at refrigerator temperatures (2-8 o C) and have demonstrated stability at room temperature for at least two months, making these constructs suitable for broad global distribution based on current results. About Trimer-Tag© Technology.
Let's personalize your content